Context: Transport of thyroid hormone across the plasma membrane is required for proper thyroid hormone action and metabolism. Several specific thyroid hormone transporters have been identified capable of facilitating uptake and/or efflux of thyroid hormones. Monocarboxylate transporter (MCT)-8, MCT10, and organic anion transporting polypeptide 1C1 (OATP1C1) are the bestcharacterized specific thyroid hormone transporters to date.
T hyroid hormone signaling is crucial for proper development and function of the adult brain. Thyroid hormone exerts its actions mainly via intracellular binding of thyroid hormone receptors (TR). Therefore, cellular entry of thyroid hormones through transporters is of critical importance. Monocarboxylate transporter (MCT)-8, MCT10, and organic anion transporting polypeptide 1C1 (OATP1C1) are the best-characterized specific thyroid hormone transporters to date (1) . The importance of thyroid hormone transporters in humans has become evident for the first time in 2004 when patients were identified with mutations in MCT8, leading to severe X-linked psychomotor retardation in combination with elevated serum T 3 concentrations (2, 3) .
We have shown earlier that MCT8 is expressed in both neurons and glial cells of the human hypothalamus (4) . In the mouse brain, Mct8 is expressed in neurons, brain capillaries, and choroid plexus (5) . Although Mct8 knockout mice show almost absent brain T 3 uptake, they show no gross neurological phenotype (6) . This striking absence of a major neurological phenotype in mice is probably due to normal T 4 brain uptake as a result of normal expression of the T 4 transporter Oatp1c1 in brain capillaries (7) and a compensatory increase of local T 4 to T 3 conversion by the type 2 deiodinase (Dio2) (6) . Therefore, the presence of other thyroid hormone transporters may be crucial to explain the interspecies difference in the phenotype of impaired MCT8 function between humans and mice. However, the distribution and importance of OATP1C1 and MCT10 in the human hypothalamus are still unknown.
At the level of the hypothalamus, thyroid hormone balance is kept through a classic negative feedback system. The TRHϪ neurons that are involved in the negative feedback of thyroid hormone are located in the paraventricular nucleus (PVN) of the hypothalamus (8) . We have previously hypothesized the existence of several neuroanatomical routes for feedback of thyroid hormone on TRH neurons in the human PVN (4). Similar routes had been proposed earlier for rodents by other groups (9, 10) .
To our knowledge, no data are available on hypothalamic MCT10 or OATP1C1 expression in humans at present. We therefore set out to study the neuroanatomical distribution of MCT10 and OATP1C1 in the human hypothalamus by means of immunohistochemistry. These studies are likely to provide more insight in the neuroanatomical pathways involved in hypothalamic thyroid hormone signaling in humans.
Materials and Methods
We studied postmortem hypothalamus specimens obtained from 10 subjects in whom serum thyroid hormone concentrations were determined in a blood sample taken within 24 h before death. In addition, we included one patient with biochemically documented thyrotoxicosis 3 wk before death. Clinicopathological data and serum thyroid hormone concentrations of these patients have been published previously and are summarized in Supplemental Table 1 
Results
Western blotting of homogenates of COS-1 cells transiently transfected with cDNA coding for MCT10 was performed to support antibody specificity and revealed bands at the expected 50 kDa plus a homodimer band of around 100 kDa. This signal could be blocked by adding the peptides used to raise the antibody, thereby further supporting specificity of the MCT10 antiserum (Supplemental Fig. 1A ). The OATP1C1 antibody did not reveal any bands at the expected molecular mass (75 kDa) or any other band, which could represent OATP1C1 in COS-1 cells transfected with cDNA coding for OATP1C1, which may be related to unfavorable antigen presentation. Therefore, we checked antibody specificity by staining of cells transfected with OATP1C1 or empty vector. As expected, cells transfected with OATP1C1 showed immunocytochemical staining of the cell membrane and cells transfected with empty vector did not show any staining (Supplemental Fig. 1B ). T 4 uptake was confirmed in OATP1C1-transfected COS-1 cells (Supplemental Fig. 1C) . Specificity of the staining procedure was further supported by negative staining with preimmune sera and antisera preadsorbed with the homologous synthetic thyroid hormone transporter peptides on hypothalamus sections (Supplemental Fig. 2) .
For detailed analysis of the expression of thyroid hormone transporters in the human hypothalamus, we systematically sampled 11 hypothalami over the entire rostrocaudal axis of the hypothalamus. We found OATP1C1 expression in glial cells scattered throughout the hypothalamus (Supplemental Fig. 3) . A more dense population of glial cells lining or in close proximity of the third ventricular wall showed OATP1C1 immunoreactivity. In addition, neuronal OATP1C1 staining was present in both magno-and parvocellular neurons of the PVN and in the supraoptic nucleus (SON) and infundibular nucleus (IFN) (Fig. 1, A and B and E and F and Supplemental Fig. 3 ). MCT10 expression was present in neurons of a number of hypothalamic nuclei, including magno-and parvocellular neurons of the PVN, in SON neurons, and in neurons of the perifornical area (Fig. 1, C and D and G and H) . The distribution patterns of transporter immunoreactivity in the hypothalamus are schematically illustrated in Fig. 2 , A-D. For both OATP1C1 and MCT10, a strong interindividual variation was observed, which did not show any clear relationship with serum thyroid hormone concentrations as measured in a blood sample taken within 24 h before death. Patient 93-121 with primary hyperthyroidism (Supplemental Table 1), who we reported previously to have very low preproTRH mRNA expression, showed a similar distribution pattern and expression level of thyroid hormone transporters compared with other subjects.
Discussion
In the present study, we investigated the expression patterns of novel thyroid hormone transporters in the human hypothalamus using immunohistochemistry. Antibody specificity was supported by absence of staining with the preimmune and preadsorbed sera. Furthermore, we could block the MCT10 staining on Western blot with transfected COS-1 cell homogenates by preadsorption with the immunizing peptides. We were not able to stain OATP1C1 on Western blots, likely due to unfavorable antigen presentation. This possibility is supported by the large variation in electrophoretic properties of OATP1C1 on sodium dodecyl sulfate-page gels as observed in microsomal fractions from transfected insect cells compared with human retinal tissue (11) . We therefore stained transfected cells with OATP1C1 to have a more similar antigen presentation as present in vivo.
Our results show ubiquitous OATP1C1 staining in astrocytes of the hypothalamus, which is in agreement with rodent data (12) . Interestingly, we also found strong neuronal staining in several hypothalamic areas including the PVN in which the TRH neurons that are involved in the negative feedback of the hypothalamus-pituitary thyroid axis are localized. We did not observe any obvious correlation between the expression of thyroid hormone transporters and serum thyroid hormone concentrations. This may be due to the limited number of observations in the present studies, although we have been able to describe a correlation between serum thyroid hormone concentrations and TRH mRNA expression earlier (13) . It is unknown whether and how MCT8, MCT10, or OATP1C1 is regulated by thyroid hormone serum concentrations. A recent study by Babu et al. (14) has shown no effect of hypothyroxinemia on the expression of MCT8. TR isoforms and MCT8 and type 3 deiodinase (Dio3) are expressed in the human PVN (4, 15) . We and other groups have proposed models for hypothalamic thyroid hormone signaling involving local T 4 to T 3 conversion by Dio2 and the subsequent transport of the biologically more active T 3 to neurons expressing TR (4, 10) . Paracrine thyroid hormone signaling in neurons as a result of T 4 to T 3 conversion in glial cells was shown in a 
recent study using coculture of neuronal and glial cell lines (16) . Neurons of the PVN do not show Dio2 immunoreactivity (4), and therefore, the function of the T 4 transporter OATP1C1 in these neurons remains unclear.
The overlap between neuronal distribution patterns of TR and MCT10 immunoreactivity suggests a clear role for this transporter in thyroid hormone signaling in the human hypothalamus (15) . The expression of OATP1C1 in glial cells suggests a role for T 4 transport into cells expressing Dio2. Earlier we reported the expression of MCT8 in these cell populations, putatively involved in the export of T 3 as MCT8 mediates both uptake and efflux in vitro (17) . Subsequent import of T 3 into neurons expressing TR could then be the primary role of MCT8 to enable binding of nuclear TR. Alternatively T 3 can be degraded by Dio3 or transported out of the cell by MCT10 and MCT8. Based on our neuroanatomical observations, we propose a model for thyroid hormone signaling in the human hypothalamus (Fig. 2E) . In view of interspecies differences between humans and rodents, it is not possible to confirm this model using functional studies.
The lateral hypothalamus, which is implicated in the regulation of food intake and body weight, is innervated by leptin sensitive neurons from the arcuate nucleus (the rodent equivalent of the human IFN) and shows sporadic Dio2 activity in rats (18) . Although in humans we did not find Dio2 and only sporadic Dio3 immunoreactivity, we have described intense MCT8 immunoreactivity in this area (4) . The presence of marked MCT10 and MCT8 and sparse Dio3 immunoreactivity in the human perifornical area suggest a neuroanatomical basis for effects of thyroid hormone on feeding behavior in humans as well, which merits further studies.
The striking differences in the neurological phenotypes between Mct8-null mice and MCT8-deficient patients may result from interspecies differences in the expression (or subset) of thyroid hormone transporters in the central nervous system (12) . The absence of a gross neurological phenotype in mice could be attributed to the existence of thyroid hormone transporters in the rodent brain compensating for the lack of MCT8 expression (12). Wirth et al. (19) have suggested that the L-type amino acid transporter Lat2 might compensate in the mouse but not in the human brain for the lack of Mct8. Furthermore, the rat brain expresses the TH transporter variants Oatp1a4 and Oatp1a5, but neither of these transporters have an ortholog in the human brain (20) .
For MCT8 there is already evidence for interspecies differences, although the effects of fatal disease should be kept in mind as a potential confounding factor. We found a widespread distribution of MCT8 in both neurons and tanycytes throughout the human hypothalamus (4). In contrast, mice show only moderate MCT8 expression levels in the para-and periventricular nucleus (5) . In agreement with studies in mice, we found scattered OATP1C1-positive cells. Moreover, we found neuronal staining in the human SON, PVN, and IFN, but whether these neurons express OATP1C1 in rodents is unclear. No data are available on MCT10 distribution in the rodent hypothalamus, and the phenotype of OATP1C1 or MCT10 deletion in mice has not been published. Therefore, the importance of these thyroid hormone transporters in central thyroid hormone signaling and the interspecies differences for OATP1C1 and MCT10 still remain to be clarified in more detail.
